Armando Santoro

Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy

V. Vaira, R. de Sanctis, R. Torrisi, 2024, International journal of molecular sciences.

Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer

R. de Sanctis, R. Torrisi, G. Masci, 2024, Biomedicines.

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients

A. Falanga, L. Barcella, F. Petrelli, 2023, Cancers.

Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy

P. Zucali, F. De Vincenzo, M. Perrino, 2023, Cancers.

Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial)

R. de Sanctis, F. Jacobs, C. Benvenuti, 2024, Journal of personalized medicine.

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

S. Cattan, J. Delord, Kyung-Hun Lee, 2024, JHEP reports : innovation in hepatology.